KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Progyny (PGNY) Operating Expenses (2018 - 2025)

Progyny (PGNY) has disclosed Operating Expenses for 8 consecutive years, with $61.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Expenses changed N/A to $61.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $219.2 million, a N/A change, with the full-year FY2025 number at $61.7 million, changed N/A from a year prior.
  • Operating Expenses was $61.7 million for Q4 2025 at Progyny, up from $51.3 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $61.7 million in Q4 2025 to a low of $17.1 million in Q1 2021.
  • A 5-year average of $39.9 million and a median of $43.6 million in 2023 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: soared 95.1% in 2022, then rose 0.58% in 2024.
  • Progyny's Operating Expenses stood at $25.3 million in 2021, then skyrocketed by 62.78% to $41.2 million in 2022, then increased by 4.63% to $43.1 million in 2023, then rose by 8.57% to $46.8 million in 2024, then soared by 31.79% to $61.7 million in 2025.
  • Per Business Quant, the three most recent readings for PGNY's Operating Expenses are $61.7 million (Q4 2025), $51.3 million (Q3 2025), and $54.6 million (Q2 2025).